🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Transplant patients must take lifelong immunosuppression in order to preven...
Status
Completed
Location
UC San Diego Health
Start Date
2019-10-25
Trial ID
NCT03916380
Treatments Being Tested
This study is designed to investigate the safety, tolerability and PK of VH...
Status
Completed
Location
GSK Investigational Site
Start Date
2022-12-02
Trial ID
NCT05631704
This is a study to evaluate the safety, tolerability and pharmacokinetics o...
Status
Completed
Location
Atlanta Center for Medical Research - Sickle Cell Subjects Only
Start Date
2020-10-26
Trial ID
NCT04586985
This study aimed to investigate the influence of uncontrolled type 1 and ty...
Status
Completed
Location
Universidade Estadual Paulista Julio de Mesquita Filho
Start Date
2008-06
Trial ID
NCT02246712
Treatments Being Tested
The main purpose of this study is to evaluate the effect of imlunestrant (L...
Status
Completed
Location
LabCorp CRU, Inc.
Start Date
2022-09-12
Trial ID
NCT05509816
Treatments Being Tested
This phase I open label study is conducted to assess the potential pharmaco...
Status
Completed
Location
Eurofins Optimed
Start Date
2016-09
Trial ID
NCT02887443
Treatments Being Tested
The objectives of this study are: * To investigate if the endogenous chole...
Status
Completed
Location
Clinical Pharmacology Trial Unit (CPTU), Karolinska University Hospital
Start Date
2011-05
Trial ID
NCT01340456
Treatments Being Tested
This is a phase I, open-label, fixed sequence design, drug-drug-interaction...
Status
Completed
Location
CTC Clinical Trials Consultants AB
Start Date
2022-11-27
Trial ID
NCT05633147
To evaluate the effect of IPI-145 on the pharmacokinetics of midazolam, a c...
Status
Completed
Location
PRA International
Start Date
2013-08
Trial ID
NCT01925911
Evaluation and validation of metabolic markers for the assessment of CYP3A ...
Status
Completed
Location
Multiple Locations
Start Date
2014-01
Trial ID
NCT02328443
Treatments Being Tested